Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease

被引:14
|
作者
Maislos, M [1 ]
Medvedovskv, V
Sztarkier, I
Yaari, A
Sikuler, E
机构
[1] Soroka UMC, Dept Med, Atherosclerosis & Metab Unit, Beer Sheva, Israel
[2] Ben Gurion Univ Negev, FOHS, IL-84105 Beer Sheva, Israel
[3] Soroka UMC, Dept Med B, Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
[5] Soroka UMC, Liver Res Lab, Beer Sheva, Israel
[6] Soroka UMC, Inst Pathol, Beer Sheva, Israel
关键词
NAFLD; animal model; Psammomys obesus; steatohepatitis;
D O I
10.1016/j.diabres.2005.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aims: Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized condition that includes a spectrum of clinicopathologic conditions ranging from steatotosis to cirrhosis and liver failure. NAFLD is usually associated with features of the metabolic syndrome. No established therapies can be offered to patients with NAFLD. An appropriate animal model of NAFLD would be of help in understanding the mechanisms of the disease and in testing novel therapeutic modalities. Available animal models, such as ob/ob and db/db mice, are unsatisfactory since they show only partial resemblance to human NAFLD. Psammomys obesus (sand rat) is a well-established model of type-2 diabetes and obesity, which shares most metabolic parameters of the human metabolic syndrome. In the present study, we hypothesized that P. obesus will also show features of non-alcoholic fatty liver disease. Methods: Experimental and control animals were fed normal rat chow or either chow to which fiber (30% wheat straw) was added for 6-18 weeks. Body weight and capillary glucose were measured regularly. At sacrifice blood samples, liver and epididymal fat were obtained. Histology of the liver was blindly determined by a pathologist. Results: The experimental group showed increased body weight. liver and abdominal fat pad mass, raised plasma glucose, insulin and lipids. Also, alanine-aminotransferase (189 +/- 76 IU versus 86 +/- 26 IU; p < 0.0001) was significantly higher in the experimental than the control group. Microscopic examination of liver tissue demonstrated marked macrovesicular fat infiltration in the experimental group while it was histologicaly normal in the control animals (liver fat score 1.7 +/- 1.0 and 0.2 +/- 0.4; p < 0.0001, respectively). Conclusions: Fed a calorie-rich diet P. obesus develops a syndrome, which shares metabolic, laboratory and histopathologic characteristics compatible with human NAFLD. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] Ghrelin: a new treatment for non-alcoholic fatty liver disease?
    Patric J. D. Delhanty
    Aart J. van der Lely
    Endocrine, 2013, 43 : 247 - 248
  • [42] What's new in non-alcoholic fatty liver disease?
    Spiers, Jessica
    Brindley, James Hallimond
    Li, Wenhao
    Alazawi, William
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (E1) : E102 - E108
  • [43] Non-alcoholic fatty liver disease - What's new
    Roeb, Elke
    Steffen, Hans-Michael
    Bojunga, Joerg
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 494 - 496
  • [44] Non-alcoholic fatty liver disease: a new epidemic in children
    Ciocca, Mirta
    Ramonet, Margarita
    Alvarez, Fernando
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2016, 114 (06): : 563 - 568
  • [45] Non-alcoholic fatty liver disease: a new threat for the cardiologist
    Tarquini, Roberto
    Lazzeri, Chiara
    Boddi, Maria
    Marra, Fabio
    Abbate, Rosanna
    Gensini, Gian Franco
    GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (09) : 660 - 669
  • [46] New insights in the pathogenesis of non-alcoholic fatty liver disease
    Gaemers, Ingrid C.
    Groen, Albert K.
    CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (03) : 268 - 273
  • [47] Ghrelin: a new treatment for non-alcoholic fatty liver disease?
    Delhanty, Patric J. D.
    van der Lely, Aart J.
    ENDOCRINE, 2013, 43 (02) : 247 - 248
  • [48] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [49] Non-alcoholic fatty liver disease and liver secretome
    Khan, Muhammad Sohaib
    Lee, Choongho
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963
  • [50] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538